AEterna Zentaris Inc (NASDAQ:AEZS)
| 0.54 Data as of Jan 29 |  +0.01 / +1.89%Today’s Change | 0.48 Today|||52-Week Range 1.54 | -10.00% Year-to-Date |
Latest AEZS News | Press Releases
No recent news for AEterna Zentaris Inc.
Today’s Trading
| Previous close | 0.53 |
| Today’s open | 0.53 |
| Day’s range | -- - -- |
| Volume | 315,900 |
| Average volume (3 months) | 1,602,607 |
| Market cap | $30.7M |
| Dividend yield | -- |
Data as of 01/29/2015
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +43.26% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -81.66% |
| P/E ratio | -- |
| Price/Sales | 6.60 |
| Price/Book | 1.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBMDPrima BioMed Ltd | +0.00 | +0.01% |
| --Protea Biosciences G... | -0.03 | -7.89% |
| FSIFlexible Solutions I... | -0.09 | -6.21% |
| IMUCImmunoCellular Thera... | +0.01 | +1.18% |
Data as of 3:50pm ET, 01/29/2015
Financials
| Next reporting date | March 24, 2015 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $6.2M |
| Annual profit (last year) | $6.8M |
| Net profit margin | -441.13% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer David A. Dodd |
Chief Financial Officer & Senior Vice President Dennis Turpin |
Corporate headquarters Québec, Quebec |
Forecasts
.